FDA-Approved Sunscreen Ingredient Bemotrizinol Reaches U.S. Store Shelves
On October 15, 2026, the first U.S. sunscreens containing bemotrizinol, an FDA-approved sunscreen ingredient, appeared on store shelves, including new products from Neutrogena.[1]
The FDA cleared bemotrizinol for use in U.S. sunscreens in June 2026, and manufacturers say the ingredient provides broad-spectrum protection against both UVA and UVB as a single chemical active.[1] Dermatologists and the Environmental Working Group point to decades of safety data and minimal skin penetration for bemotrizinol compared with some older chemical sunscreens.[1]
In June 2026 the FDA approval paved the way for manufacturers to reformulate products and begin U.S. rollouts that industry observers say strengthen available UVA coverage.[1]
Show source details & analysis (1 source)
📌 Key Facts
- The FDA approved the sunscreen ingredient bemotrizinol (BEMT) in June 2026 for use in U.S. products.
- On October 15, 2026, PBS reported that the first U.S. sunscreens with BEMT, including from Neutrogena, are now on store shelves.
- BEMT offers broad-spectrum protection against both UVA and UVB radiation as a single chemical-based active, helping fill a gap in strong UVA protection.
- Dermatologists and the Environmental Working Group highlight decades of safety data and minimal skin penetration for BEMT compared with some older chemical sunscreens.
📰 Source Timeline (1)
Follow how coverage of this story developed over time